Last reviewed · How we verify
NCT05017961: BMAC
Comparing Efficacy of Bone Marrow Aspirate Concentrate (BMAC) Combined With Allograft in Treatment of Calcaneus Fractures
NA trial testing Autograft in Fractures, Bone. Withdrawn.
10 July 2019
Quick facts
| Lead sponsor | University of Alabama at Birmingham |
|---|---|
| Phase | NA |
| Status | Withdrawn |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Start date | 10 July 2019 |
| Primary completion | 10 July 2019 |
| Estimated completion | 10 July 2019 |
Drugs / interventions tested
- Autograft
- Allograft only
- Allograft combined with BMAC
Conditions studied
- Fractures, Bone — all drugs for Fractures, Bone →
Sponsor
University of Alabama at Birmingham
Who can join
Adults 18 to 75, any sex, with Fractures, Bone. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to evaluate the efficacy of BMAC when used in conjunction with viable allograft bone for treating displaced intra-articular calcaneal fractures, in terms of rate of allograft incorporation into the host tissue, bone healing, and functional outcome.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05017961
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Autograft
Trials testing the same drug.
- NCT04855175 — Evaluation of Cranioplasty Using Native Bone Autograft Versus Synthetic Bone Allograft · NA · terminated
- NCT02924571 — BMAC & Allograft vs BMP-2 · NA · completed
- NCT03681938 — Indication to Transplant Patients With High Risk B Cells Lymphoma in Metabolic Complete Remission? · unknown
- NCT03005106 — StrataGraft® Skin Tissue in the Promotion of Autologous Skin Regeneration of Complex Skin Defects Due to Thermal Burns T · Phase 3 · completed
- NCT03005054 — StrataGraft® Skin Tissue as an Alternative to Autografting Full-thickness Complex Skin Defects · Phase 2 · terminated
Other recruiting trials for Fractures, Bone
Currently open trials in the same condition.
- NCT06812481 — Anticholinergic Burden and Osteoporosis in Rheumatoid Arthritis · recruiting
- NCT06754137 — Assessing AI-Supported Fracture Detection in Emergency Care Units · NA · recruiting
- NCT06113211 — Nonopioid Pain Control Regimen After Open Reduction and Internal Fixation of Traumatic Fractures · Phase 4 · recruiting
- NCT06013852 — Boneview-ED - Impact of Artificial Intelligence Detecting Fractures in the Emergence Department : a Pragmatic Prospectiv · NA · recruiting
- NCT06256458 — Prospective Registry to Evaluate Outcomes of NanoBone® Bone Graft in Acute Trauma · recruiting
Other University of Alabama at Birmingham trials
Trials by the same sponsor.
- NCT04922229 — Comparative Effectiveness in the Management of Irreversible Pulpitis · NA · not yet recruiting
- NCT05060380 — Feasibility of a Novel Resistance Exercise in Individuals With Osteoporosis · NA · withdrawn
- NCT04768777 — Behavioral Intervention for Physical Activity and Sexual Dysfunction in Multiple Sclerosis · NA · not yet recruiting
- NCT06320951 — VITAL-IMPACT: Improving Cardiometabolic Health in Black Individuals Through Therapeutic Augmentation of Cyclic Guanosine · Phase 2 · not yet recruiting
- NCT07564934 — Leveraging Extended Reality Exergaming and Telehealth to Improve Physical Activity and Health in Children With Disabilit · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05017961 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Alabama at Birmingham
- Last refreshed: 1 August 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05017961.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing